Quantitative CK and CK-MB Control Material - Vietnam Registration 2301096ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Quantitative CK and CK-MB Control Material in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2301096ĐKLH/BYT-HTTB and manufactured by BioSystems S.A..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2301096ĐKLH/BYT-HTTB
19008862/ĐKLH-BYT-TB-CT
CK-MB CONTROL SERUM II
18061
Technical Details
CK-MB Control Serum II is used to control the quality of quantitative creatin kinase (CK) and creatin kinase-MB (CK-MB) tests in clinical laboratories and is provided with acceptable value ranges.
Dates and Status
Oct 03, 2023